A detailed history of Entry Point Capital, LLC transactions in Si Bone, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 8,038 shares of SIBN stock, worth $121,775. This represents 0.15% of its overall portfolio holdings.

Number of Shares
8,038
Previous 13,906 42.2%
Holding current value
$121,775
Previous $228 Million 54.34%
% of portfolio
0.15%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$11.93 - $16.34 $70,005 - $95,883
-5,868 Reduced 42.2%
8,038 $104 Million
Q1 2024

May 14, 2024

BUY
$15.15 - $21.58 $92,611 - $131,918
6,113 Added 78.44%
13,906 $228 Million
Q4 2023

Feb 14, 2024

BUY
$15.75 - $21.38 $122,739 - $166,614
7,793 New
7,793 $164 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $520M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.